Open AccessManagement of Psuedomonas Keratitis: a review article
Author(s) -
Mouna Mohamad Alsaad
Publication year - 2017
Publication title -
the international arabic journal of antimicrobial agents
Language(s) - English
Resource type - Journals
ISSN - 2174-9094
DOI - 10.3823/813
Subject(s) - keratitis , medicine , ciprofloxacin , corneal perforation , perforation , intensive care medicine , gentamicin , pseudomonas , cephalosporin , dermatology , surgery , antibiotics , microbiology and biotechnology , visual acuity , bacteria , biology , materials science , genetics , metallurgy , punching
Bacterial keratitis can lead to severe vision loss and corneal scarring, and possibly perforation. Early and appropriate management is a key factor in decreasing and preventing complication.
Pubmed and Medline were searched for articles related to Pseudomonas keratitis between year 2000 and 2017 to get current guidelines about the management of Pseudomonas keratitis. These articles are reviewed in this review article and information related to management is summarized.
The most used agents to treat Pseudomonas are either aminoglycosides (usually gentamicin) fortified with a cephalosporin or mono therapy with a fluoroquinolones usually ciprofloxacin. In most areas, most strains of Pseudomonasare sensitive to ciprofloxacin. The role of topical steroids is discussed, as well as, available options for treatment of multi drug resistant Pseudomonas.